Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Facelift complications eased with help of new 3-D imaging technique

28.01.2014
Millions of people each year remove wrinkles, soften creases and plump up their lips by injecting a gel-like material into their facial tissue. These cosmetic procedures are sometimes called “liquid facelifts” and are said to be minimally invasive.

It’s rare, but sometimes things go wrong. In a matter of minutes, patients’ skin can turn red or blotchy white and the injected area becomes painful. Vital blood supply to the face is restricted and if untreated, parts of the tissue will die. That scenario is irreversible and can leave deep scars.


Siavash Yousefi, U of Washington

This image shows a mouse ear after a successful cosmetic filler injection. The filler, in green, rests in the tissue without blocking the blood vessels and veins.

Physicians haven’t been able to pinpoint why this happens because until now it was difficult to see how the injected fluid, or filler, behaves in facial tissue.

New imaging technology from University of Washington engineers allows scientists to analyze what happens within the smallest blood vessels during an injection. This finding could be used to prevent accidents during procedures and help clinicians reverse the ill effects if an injection doesn’t go as planned.

“Filler-induced tissue death can be a really devastating complication for the patient and provider,” said Shu-Hong (Holly) Chang, a UW assistant professor of ophthalmology specializing in plastic and reconstructive surgery. “This noninvasive imaging technique provides far better detail than I’ve ever seen before and helped us figure out why this is happening.”

Using this technology, Chang and her team saw that complications arose when filler was inadvertently injected into the bloodstream rather than in the intended soft tissues of the face. The gel builds up in a vessel, blocking blood movement and oxygen exchange. The team tested this in the ears of mice, which offer a model of what can happen in the blood vessels of a human face, Chang said.

She presented the results in November at the annual meeting of the American Society of Ophthalmic Plastic and Reconstructive Surgery showing that filler injections into blood vessels are most likely the cause of tissue death and other complications associated with the cosmetic procedure.

Ruikang Wang, a UW professor of bioengineering, and his lab pioneered this fine-resolution imaging, called optical microangiography. It can turn out 3-D images of the body’s vascular network by shining a light onto the tissue without touching it or adding any fluorescent dyes.

“We can visualize how blood responds to the cosmetic filler gel, even looking at the responses of each individual vessel. No other technique can provide this level of scrutiny,” Wang said.

The optical imaging technique operates on the same concept as ultrasound, which leverages changes in sound to detect structures. This technique instead uses light to repeatedly scan tissue cross-sections, delineating unmoving pieces (surrounding tissues) from moving segments (blood cells in vessels). Researchers compare image frames and piece together the complex visual web.

This technology can see blood vessels as small as 5 microns in diameter. Capillaries, the smallest vessels in our bodies, are about 7 microns in diameter and a red blood cell is usually 3 to 5 microns wide.

“Our niche is imaging the microvascular system,” said team member Siavash Yousefi, a UW graduate student in bioengineering. Other applications of the technology include analyzing how wounds heal, tracking what happens during strokes and traumatic brain injuries, and imaging human eyes to study diseases such as glaucoma and macular degeneration.

Cosmetic filler procedures have surged worldwide in recent years, particularly in Europe and Asia. In 2012 in the U.S. about 2 million procedures were performed. Up to 800 patients reportedly suffered serious complications, including potentially permanent disfigurement.

During the procedure, a practitioner injects the gel-like solution, often a natural substance called hyaluronic acid, multiple times into a person’s face. Restriction of blood to the tissues, called ischemia, often doesn’t show up until later, when the patient develops pain and sees changes on the surface of the skin, meaning the tissue is dying.

Some practitioners suggest using massage and warm compresses to treat the area, while others tell patients to take aspirin, but the field doesn’t have a standard course of action for treating these complications, Chang said. She has been called in for several emergencies to treat other practitioners’ patients who show signs of a failed procedure. This can lead to tissue death and even blindness if the affected area is near the eyes.

With this new understanding, practitioners can try to reverse the effect of vascular blockage by injecting an enzyme that dissolves hyaluronic acid fillers. The research team is now testing all types of available cosmetic fillers to see if their results hold on each brand and evaluating new treatments for reversing procedure complications.

“Our lab is trying to develop novel and clinically useful biomedical imaging techniques for early diagnosis, treatment and management of human diseases. Using this technology to better understand facelift complications is a perfect example that fulfills this mission,” Wang said.

The research was funded in part by the organization Research to Prevent Blindness and a Latham Vision Research Innovation Award.

For more information, contact Yousefi at siavash@uw.edu or 541-602-9592; Chang at shuchang@uw.edu or 206-897-4611; and Wang at wangrk@uw.edu or 206-616-5025.

Michelle Ma | EurekAlert!
Further information:
http://www.uw.edu

More articles from Health and Medicine:

nachricht Speed data for the brain’s navigation system
06.12.2016 | Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE)

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Robot on demand: Mobile machining of aircraft components with high precision

06.12.2016 | Power and Electrical Engineering

A new dead zone in the Indian Ocean could impact future marine nutrient balance

06.12.2016 | Earth Sciences

Significantly more productivity in USP lasers

06.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>